Given how hard the global economy got hit during the COVID-19 pandemic, it’s a bit surprising there weren’t more job cuts in the biopharma industry. Still, as biopharma companies focus on efficiencies and close sites, jobs are getting lost. Here’s a look.
J&J Closes South San Francisco Site
Johnson & Johnson filed a WARN notice with California regulators, announcing the closure of its facility in South San Francisco. As part of the closure, it is relocating 73 jobs out of state, specifically to Titusville, New Jersey, if they agree to the move. Otherwise, they will be laid off.
The site is home to several divisions, with the largest job cuts at Actelion Pharmaceuticals U.S., which J&J acquired in 2017. There are 36 positions associated with